Company Name Eisai Co., Ltd. Date Established December 6, 1941 Head Office 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan Telephone 81-3-3817-3700 Representatives Haruo Naito, President and CEO (Representative Executive Officer) Nobuo Deguchi, Deputy President (Representative Executive Officer) Hideaki Matsui, Executive Vice President (Representative Executive Officer) Capital 44,985 million Yen (as of March 31, 2010) Sales Consolidated : 803,152 million Yen Non-Consolidated : 444,680 million Yen (The year ended March 31, 2010) Scope of Business Manufacturing and marketing of pharmaceutical drugs, over-the-counter drugs and Pharmaceuticals Production Systems and Equipment. Employees Consolidated : 11,415 Non-Consolidated : 4,367  (as of March 31, 2010) Communication Offices 67 Communication Offices in Japan  (as of March 31, 2010) Production Plants Misato Plant (Saitama Prefecture) Kawashima Plant (Gifu Prefecture) Kashima Business Office (Ibaraki Prefecture) Sannova Co., Ltd. (Gunma Prefecture) Research Triangle Park (U.S.A.) Eisai Manufacturing Ltd. (U.K.) Suzhou Plant of Eisai China Inc. (China) Eisai Pharmatechnology & Manufacturing Pvt. Ltd. (India), etc. Laboratories Tsukuba Research Laboratories (Ibaraki Prefecture) Kawashima Laboratory (Gifu Prefecture) KAN Research Institute, Inc. (Hyogo Prefecture) Morphotek, Inc. (U.S.A.) Eisai Inc. (U.S.A.) Eisai Ltd. (U.K.), etc. Overseas Sales Offices Eisai Inc. (U.S.A.) Eisai Ltd. (U.K.) Eisai GmbH (Germany) Eisai S.A.S. (France) Eisai China Inc. (China) Eisai Korea Inc. (South Korea), etc.